Reports - Gene Synthesis Market
Biotechnology and Life SciencesGene Synthesis Market
Gene Synthesis Market Valuation and Future Projections to 2035 by End User (Academic and Research Institutes, Biopharmaceutical Companies, Contract Research Organizations), by Method (Oligonucleotide Synthesis, Gene Assembly), by Region (North America, Europe, Asia Pacific, Latin America
Industry Leaders Trust Us For Actionable Intelligence
Table of Contents
Chapter 1 Executive Dashboard
1. Strategic Imperatives
Chapter 2 Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Chapter 3 Global Gene Synthesis Market - Segment Analysis
1. Overview
2. Global Gene Synthesis Market, 2021 - 2035 (USD Million)
3. Global Gene Synthesis Market - by Product
3.1. By Short mers single-stranded oligos (ssDNA)
3.2. By Linear double-stranded gene fragments (dsDNA)
3.3. By Circular Clonal Plasmids
4. Global Gene Synthesis Market - by Technology
4.1. By Polymerase Chain Reaction (PCR)
4.2. By Oligonucleotide Synthesis
4.3. By Gene Assembly
4.4. By Site-directed mutagenesis
5. Global Gene Synthesis Market - by End User
5.1. By Academic and Research Institutes
5.2. By Pharmaceutical Companies
5.3. By Biotechnology Companies
5.4. By Contract Research Organisations
6. Global Gene Synthesis Market - by Applications
6.1. By Research & Development
6.2. By Diagnostics
6.3. By Therapeutics
6.4. By Others
7. Global Gene Synthesis Market - by Services
7.1. By Gene Synthesis Service
7.2. By GMP Gene Synthesis
7.3. By Gene Fragments Service
7.4. By Others
8. Global Gene Synthesis Market - by Final Usage
8.1. By Nucleic Acid Based Vaccines
8.2. By Cell and Gene Therapies
8.3. By Protein/mAb Engineering
8.4. By Genome Programming
9. Global Gene Synthesis Market - by region
9.1. North America
9.2. Europe
9.3. Asia Pacific
9.4. Latin America
9.5. Middle East & Africa
10. Market comparative analysis
Chapter 4 North America Gene Synthesis Market - Segment Analysis
1. Overview
2. North America Gene Synthesis Market, 2021 - 2035 (USD Million)
3. North America Gene Synthesis Market - by Product
3.1. By Short mers single-stranded oligos (ssDNA)
3.2. By Linear double-stranded gene fragments (dsDNA)
3.3. By Circular Clonal Plasmids
4. North America Gene Synthesis Market - by Technology
4.1. By Polymerase Chain Reaction (PCR)
4.2. By Oligonucleotide Synthesis
4.3. By Gene Assembly
4.4. By Site-directed mutagenesis
5. North America Gene Synthesis Market - by End User
5.1. By Academic and Research Institutes
5.2. By Pharmaceutical Companies
5.3. By Biotechnology Companies
5.4. By Contract Research Organisations
6. North America Gene Synthesis Market - by Applications
6.1. By Research & Development
6.2. By Diagnostics
6.3. By Therapeutics
6.4. By Others
7. North America Gene Synthesis Market - by Services
7.1. By Gene Synthesis Service
7.2. By GMP Gene Synthesis
7.3. By Gene Fragments Service
7.4. By Others
8. North America Gene Synthesis Market - by Final Usage
8.1. By Nucleic Acid Based Vaccines
8.2. By Cell and Gene Therapies
8.3. By Protein/mAb Engineering
8.4. By Genome Programming
Chapter 5 Europe Gene Synthesis Market - Segment Analysis
1. Overview
2. Europe Gene Synthesis Market, 2021 - 2035 (USD Million)
3. Europe Gene Synthesis Market - by Product
3.1. By Short mers single-stranded oligos (ssDNA)
3.2. By Linear double-stranded gene fragments (dsDNA)
3.3. By Circular Clonal Plasmids
4. Europe Gene Synthesis Market - by Technology
4.1. By Polymerase Chain Reaction (PCR)
4.2. By Oligonucleotide Synthesis
4.3. By Gene Assembly
4.4. By Site-directed mutagenesis
5. Europe Gene Synthesis Market - by End User
5.1. By Academic and Research Institutes
5.2. By Pharmaceutical Companies
5.3. By Biotechnology Companies
5.4. By Contract Research Organisations
6. Europe Gene Synthesis Market - by Applications
6.1. By Research & Development
6.2. By Diagnostics
6.3. By Therapeutics
6.4. By Others
7. Europe Gene Synthesis Market - by Services
7.1. By Gene Synthesis Service
7.2. By GMP Gene Synthesis
7.3. By Gene Fragments Service
7.4. By Others
8. Europe Gene Synthesis Market - by Final Usage
8.1. By Nucleic Acid Based Vaccines
8.2. By Cell and Gene Therapies
8.3. By Protein/mAb Engineering
8.4. By Genome Programming
Chapter 6 Asia Pacific Gene Synthesis Market - Segment Analysis
1. Overview
2. Asia Pacific Gene Synthesis Market, 2021 - 2035 (USD Million)
3. Asia Pacific Gene Synthesis Market - by Product
3.1. By Short mers single-stranded oligos (ssDNA)
3.2. By Linear double-stranded gene fragments (dsDNA)
3.3. By Circular Clonal Plasmids
4. Asia Pacific Gene Synthesis Market - by Technology
4.1. By Polymerase Chain Reaction (PCR)
4.2. By Oligonucleotide Synthesis
4.3. By Gene Assembly
4.4. By Site-directed mutagenesis
5. Asia Pacific Gene Synthesis Market - by End User
5.1. By Academic and Research Institutes
5.2. By Pharmaceutical Companies
5.3. By Biotechnology Companies
5.4. By Contract Research Organisations
6. Asia Pacific Gene Synthesis Market - by Applications
6.1. By Research & Development
6.2. By Diagnostics
6.3. By Therapeutics
6.4. By Others
7. Asia Pacific Gene Synthesis Market - by Services
7.1. By Gene Synthesis Service
7.2. By GMP Gene Synthesis
7.3. By Gene Fragments Service
7.4. By Others
8. Asia Pacific Gene Synthesis Market - by Final Usage
8.1. By Nucleic Acid Based Vaccines
8.2. By Cell and Gene Therapies
8.3. By Protein/mAb Engineering
8.4. By Genome Programming
Chapter 7 Latin America Gene Synthesis Market - Segment Analysis
1. Overview
2. Latin America Gene Synthesis Market, 2021 - 2035 (USD Million)
3. Latin America Gene Synthesis Market - by Product
3.1. By Short mers single-stranded oligos (ssDNA)
3.2. By Linear double-stranded gene fragments (dsDNA)
3.3. By Circular Clonal Plasmids
4. Latin America Gene Synthesis Market - by Technology
4.1. By Polymerase Chain Reaction (PCR)
4.2. By Oligonucleotide Synthesis
4.3. By Gene Assembly
4.4. By Site-directed mutagenesis
5. Latin America Gene Synthesis Market - by End User
5.1. By Academic and Research Institutes
5.2. By Pharmaceutical Companies
5.3. By Biotechnology Companies
5.4. By Contract Research Organisations
6. Latin America Gene Synthesis Market - by Applications
6.1. By Research & Development
6.2. By Diagnostics
6.3. By Therapeutics
6.4. By Others
7. Latin America Gene Synthesis Market - by Services
7.1. By Gene Synthesis Service
7.2. By GMP Gene Synthesis
7.3. By Gene Fragments Service
7.4. By Others
8. Latin America Gene Synthesis Market - by Final Usage
8.1. By Nucleic Acid Based Vaccines
8.2. By Cell and Gene Therapies
8.3. By Protein/mAb Engineering
8.4. By Genome Programming
Chapter 8 Middle East & Africa Gene Synthesis Market - Segment Analysis
1. Overview
2. Middle East & Africa Gene Synthesis Market, 2021 - 2035 (USD Million)
3. Middle East & Africa Gene Synthesis Market - by Product
3.1. By Short mers single-stranded oligos (ssDNA)
3.2. By Linear double-stranded gene fragments (dsDNA)
3.3. By Circular Clonal Plasmids
4. Middle East & Africa Gene Synthesis Market - by Technology
4.1. By Polymerase Chain Reaction (PCR)
4.2. By Oligonucleotide Synthesis
4.3. By Gene Assembly
4.4. By Site-directed mutagenesis
5. Middle East & Africa Gene Synthesis Market - by End User
5.1. By Academic and Research Institutes
5.2. By Pharmaceutical Companies
5.3. By Biotechnology Companies
5.4. By Contract Research Organisations
6. Middle East & Africa Gene Synthesis Market - by Applications
6.1. By Research & Development
6.2. By Diagnostics
6.3. By Therapeutics
6.4. By Others
7. Middle East & Africa Gene Synthesis Market - by Services
7.1. By Gene Synthesis Service
7.2. By GMP Gene Synthesis
7.3. By Gene Fragments Service
7.4. By Others
8. Middle East & Africa Gene Synthesis Market - by Final Usage
8.1. By Nucleic Acid Based Vaccines
8.2. By Cell and Gene Therapies
8.3. By Protein/mAb Engineering
8.4. By Genome Programming
Chapter 9 Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
Chapter 10 COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Chapter 11 Marketing Strategy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Chapter 12 Competitive Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Chapter 13 Company Profiles
1. THERMO FISHER SCIENTIFIC INC.
2. GENSCRIPT
3. INTEGRATED DNA TECHNOLOGIES INC.
4. ORIGENE TECHNOLOGIES INC.
5. BIOMATIK
6. TWIST BIOSCIENCE
7. BROOKS AUTOMATION INC.
8. BOSTER BIOLOGICAL TECHNOLOGY
9. PROTEOGENIX INC.
10. PROMAB BIOTECHNOLOGIES INC.
11. MERCK KGAA
12. EUROFINS GENOMICS
13. BIO BASIC INC.
14. Gene Universal Inc.
Chapter 14 Key Primary Respondents - VERBATIM
Chapter 15 Discussion Guide
Chapter 16 Customization Offered
Chapter 17 Annexure
Chapter 18 List of Figures
Chapter 19 List of Tables
Chapter 20 List of Abbreviations
FAQ‘s
Related Reports
Contact
Toll Free Number+1 (877) 462-2282
© 2025 Vantage Market Research. All right reserved
Secured By